Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mancuso

Showing results (111-120 of 219) with videos related to

Pageof 22
Sort By:
Journal of Synchrotron Radiation|March 12, 2019
A versatile liquid-jet setup for the European XFELJ Schulz, J Bielecki, R B Doak, et al.
Diabetes & Vascular Disease Research|May 14, 2019
Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studiesJie Liu, Lisa Tarasenko, Steven G Terra, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 10, 2018
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized StudySam Miller, Tania Krumins, Haojin Zhou, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 22, 2017
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized StudyGeorge Grunberger, Sarah Camp, Jeremy Johnson, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Phage-mediated lysis does not determine <i>Cutibacterium acnes</i> colonization on human skinA Delphine Tripp, Evan B Qu, Ishaq Balogun, et al.
Obesity (Silver Spring, Md.)|February 6, 2010
Increased food intake and energy expenditure following administration of olanzapine to healthy menRobert J Fountaine, Ann E Taylor, James P Mancuso, et al.
British Journal of Cancer|October 23, 2008
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityR Torrisi, V Bagnardi, A Cardillo, et al.
The New England Journal of Medicine|April 9, 2004
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterolMargaret E Brousseau, Ernst J Schaefer, Megan L Wolfe, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2019
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 22, 2019
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Pageof 22

Showing results (111-120 of 219) with videos related to

Sort By:
Pageof 22
Journal of Synchrotron Radiation|March 12, 2019
A versatile liquid-jet setup for the European XFELJ Schulz, J Bielecki, R B Doak, et al.
Diabetes & Vascular Disease Research|May 14, 2019
Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studiesJie Liu, Lisa Tarasenko, Steven G Terra, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 10, 2018
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized StudySam Miller, Tania Krumins, Haojin Zhou, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 22, 2017
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized StudyGeorge Grunberger, Sarah Camp, Jeremy Johnson, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Phage-mediated lysis does not determine <i>Cutibacterium acnes</i> colonization on human skinA Delphine Tripp, Evan B Qu, Ishaq Balogun, et al.
Obesity (Silver Spring, Md.)|February 6, 2010
Increased food intake and energy expenditure following administration of olanzapine to healthy menRobert J Fountaine, Ann E Taylor, James P Mancuso, et al.
British Journal of Cancer|October 23, 2008
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityR Torrisi, V Bagnardi, A Cardillo, et al.
The New England Journal of Medicine|April 9, 2004
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterolMargaret E Brousseau, Ernst J Schaefer, Megan L Wolfe, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2019
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 22, 2019
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Pageof 22